which glp is retatrutide 10mg — Triple Agonist GLP-1/GIP/Glucagon Research Peptide Retatrutide | Triple Agonist Research

Timing Your Doses The timing of your Retatrutide injection can influence how you experience retatrutide side effects

Use tirzepatide until the drug is approved

This prevents the medication from breaking down and losing its effectiveness

This may include people with active cancer concerns, immune disorders, uncontrolled chronic illness, pregnancy or plans for pregnancy, complex medication regimens, bleeding disorders, severe allergies, kidney or liver concerns, unexplained symptoms, or a history of poor reactions to injectable products

Retatrutide is being studied for activity at GIP, GLP-1, and glucagon receptors